E. Pittermann
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- BRCA gene mutations in cancer
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 15
- Acute Myeloid Leukemia Research 13
-
- Retinoids in leukemia and cellular processes 4
- Co-authors
- Michael Pfeilstöcker (16 shared papers)Thomas Nösslinger (7 shared papers)Heinz Tüchler (7 shared papers)Hadwiga Nowotny (3 shared papers)R. Heinz (11 shared papers)Elisabeth Koller (6 shared papers)Ernst Schlögl (2 shared papers)Thomas H. Helbich (1 shared paper)
- Journals
- Annals of Hematology (6 papers)Leukemia Research (5 papers)Journal of Molecular Medicine (2 papers)Blood (2 papers)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- AustriaUnited StatesSlovakia
In The Last Decade
E. Pittermann
33 papers receiving 392 citations
Peers
Comparison fields: 5 of 63
- Hematology 263
- Genetics 107
- Emergency Medicine 36
- Pathology and Forensic Medicine 60
- Genetics 73
Countries citing papers authored by E. Pittermann
This map shows the geographic impact of E. Pittermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Pittermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Pittermann more than expected).
Fields of papers citing papers by E. Pittermann
This network shows the impact of papers produced by E. Pittermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Pittermann. The network helps show where E. Pittermann may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Pittermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 96 | |
| 2 | 1999 | 71 | |
| 3 | 2000 | 68 | |
| 4 | 2001 | 47 | |
| 5 | 2002 | 23 | |
| 6 | 1999 | 19 | |
| 7 | 2011 | 14 | |
| 8 | 1995 | 14 | |
| 9 | 2011 | 7 | |
| 10 | 1995 | 6 | |
| 11 | Peptichemio in the therapy of malignancies (phase-I-study). The evaluation committee. | 1974 | 6 |
| 12 | 2001 | 6 | |
| 13 | 1998 | 5 | |
| 14 | 2000 | 3 | |
| 15 | 1999 | 3 | |
| 16 | [Plasma exchange therapy in hematology]. | 1985 | 3 |
| 17 | 1974 | 3 | |
| 18 | [Column-chromatographic enrichment of DNA-polymerase activity in leukemia]. | 1973 | 3 |
| 19 | 2002 | 2 | |
| 20 | 2010 | 2 |
About E. Pittermann
E. Pittermann is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 37 papers that have together received 417 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (4 papers), Neutropenia and Cancer Infections (4 papers), Metabolism and Genetic Disorders (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (263 citations), Genetics (107 citations), Emergency Medicine (36 citations), Pathology and Forensic Medicine (60 citations) and Genetics (73 citations). E. Pittermann has collaborated with scholars based in Austria, United States and Slovakia. Frequent co-authors include Michael Pfeilstöcker, Thomas Nösslinger, Heinz Tüchler, Hadwiga Nowotny, R. Heinz, Elisabeth Koller, Ernst Schlögl, Thomas H. Helbich, Alexander Friedmann and Peter J. Oefner. Their work appears in journals such as Annals of Hematology, Leukemia Research, Journal of Molecular Medicine, Blood and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.